These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8207401)

  • 21. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein.
    Martínez I; Melero JA
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2215-20. PubMed ID: 9747731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N; Trudel M; Simard C
    Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic analysis of the F protein of the bovine respiratory syncytial virus: identification of two distinct antigenic sites involved in fusion inhibition.
    Matheise JP; Walravens K; Collard A; Coppe P; Letesson JJ
    Arch Virol; 1995; 140(6):993-1005. PubMed ID: 7541983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
    McGill A; Marsh R; Craft AW; Toms GL
    J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic and molecular analyses of the variability of bovine respiratory syncytial virus G glycoprotein.
    Prozzi D; Walravens K; Langedijk JP; Daus F; Kramps JA; Letesson JJ
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():359-66. PubMed ID: 9018058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
    Cane PA
    J Med Virol; 1997 Apr; 51(4):297-304. PubMed ID: 9093944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein.
    García-Beato R; Martínez I; Francí C; Real FX; García-Barreno B; Melero JA
    Virology; 1996 Jul; 221(2):301-9. PubMed ID: 8661440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein.
    Chargelegue D; Obeid OE; Shaw DM; Denbury AN; Hobby P; Hsu SC; Steward MW
    Immunol Lett; 1997 Jun; 57(1-3):15-7. PubMed ID: 9232419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic and immunogenic analysis of group A and group B respiratory syncytial virus G proteins expressed from recombinant baculoviruses.
    Sullender WM; Britt WJ
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():641-8. PubMed ID: 8627252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
    Spender LC; Hussell T; Openshaw PJ
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response.
    Akerlind-Stopner B; Utter G; Norrby E; Mufson MA
    J Med Virol; 1995 Oct; 47(2):120-5. PubMed ID: 8830114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactive and group-specific immune responses to a neutralizing epitope of the human respiratory syncytial virus fusion protein.
    Corvaisier C; Bourgeois C; Pothier P
    Arch Virol; 1997; 142(6):1073-86. PubMed ID: 9228999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.
    Forster J; Maier O; Löbbert J; Kaufmehl K; Streckert HJ; Werchau H
    Infection; 1996; 24(6):407-11. PubMed ID: 9007586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.
    Streckert HJ; Philippou S; Riedel F
    Arch Virol; 1996; 141(3-4):401-10. PubMed ID: 8645083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection.
    Simard C; Nadon F; Séguin C; Thien NN; Binz H; Basso J; Laliberté JF; Trudel M
    Vaccine; 1997 Mar; 15(4):423-32. PubMed ID: 9141214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
    Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
    J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity.
    Palomo C; García-Barreno B; Peñas C; Melero JA
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():669-75. PubMed ID: 2005433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.